Serum uromodulin and Roux-en-Y gastric bypass: improvement of a marker reflecting nephron mass

Early diagnosis of kidney disease in obese patients and in such patients with type 2 diabetes (T2D) can significantly improve treatment outcome. Serum uromodulin (sUMOD) may be a sensitive parameter for early detection of nephropathy.

Source: Surgery for Obesity and Related Diseases - May 14, 2019 Category: Surgery Authors: Katharina M. Scheurlen, Adrian T. Billeter, Stefan Kopf, Victor Herbst, Matthias Block, Peter P. Nawroth, Martin Zeier, J ürgen E. Scherberich, Beat P. Müller-Stich Tags: Original article Source Type: research